This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UKIPO won’t allow untimely filing by Shenzhen Sibionics in trademark spat with Sirio Pharma

By Abhishek Kumar ( October 11, 2024, 18:30 GMT | Insight) -- Medical technology start-up Shenzhen Sibionics’ failure to file a timely response to trademark opposition proceedings initiated by Sirio Pharma won’t be excused by the UK Intellectual Property Office. In a decision rendered last week, the UKIPO said it found no “extenuating circumstances” to justify allowing the late response, leaving Sibionics’ trademark application undefended and the company forfeiting its November 2023 filing date and August 2023 priority date.Chinese medical technology start-up Shenzhen Sibionics’ request to file a late response in a trademark dispute with Sirio Pharma was turned down by the UK’s Intellectual Property Office, or UKIPO, on Friday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections